New Delhi, February 19 Zydus Lifesciences announced on Thursday that it has launched its first biosimilar, developed indigenously, for the treatment of visual impairment.Anyra, the country's first biosimilar of Aflibercept 2 mg, is indicated for the treatment of visual impairment caused by...
aflibercept
anyra
bayer
biologics
biosimilar
diabetes
drug development
gujarat
healthcare
india
ophthalmic care
pharmaceuticals
regeneron pharmaceuticals
visual impairment
zydus lifesciences